FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy

FASEB Journal

Volumn 24, Issue 8, 2010, Pages 2660-2669

  Zheng, Bin ^a   Ohkawa, Sakae ^a   Li, Haiyan ^a   Roberts Wilson, Tiffany K ^b   Price, S Russ ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Diabetes; Transcription

Indexed keywords

ADENOVIRUS VECTOR; ATROGIN 1; DEXAMETHASONE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR SP1; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE INACTIVATION; GENETIC TRANSCRIPTION; INSULIN DEFICIENCY; MALE; MOLECULAR INTERACTION; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEROIDOGENESIS;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR ATROPHY; RATS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN;

ADENOVIRIDAE; RATTUS;

EID: 77955816283     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-151480     Document Type: Article

References (59)

1. Hall-Angerås, M., Angerås, U., Zamir, O., Hasselgren, P. O., and Fischer, J. E. (1991) Effect of the glucocorticoid receptor antagonist RU38486 on muscle protein degradation in sepsis. Surgery 109, 468-473
2. Konagaya, M., Bernard, P. A., and Max, S. R. (1986) Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 119, 375-380
3. Price, S. R., England, B. K., Bailey, J. L., Van Vreede, K., and Mitch, W. E. (1994) Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNA levels in rat muscle. Am. J. Physiol. Cell Physiol. 267, C955-C960
4. Combaret, L., Taillandier, D., Dardevet, D., Bechet, D., Ralliere, C., Claustre, A., Grizard, J., and Attaix, D. (2004) Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Biochem. J. 378, 239-246
5. Auclair, D., Garrel, D. R., Zerouala, A. C., and Ferland, L. H. (1997) Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am. J. Physiol. Cell Physiol. 272, C1007-C1016
6. Chrysis, D., and Underwood, L. E. (1999) Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Endocrinology 140, 5635-5641
7. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412
8. Du, J., Mitch, W. E., Wang, X., and Price, S. R. (2000) Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-κB. J. Biol. Chem. 275, 19661-19666
9. Marinovic, A. C., Zheng, B., Mitch, W. E., and Price, S. R. (2002) Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J. Biol. Chem. 277, 16673-16681
10. Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., and Glass, D. J. (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395-403
11. Cai, D., Frantz, J. D., Tawa, N. E., Jr., Melendez, P. A., Oh, B. C., Lidov, H. G., Hasselgren, P. O., Frontera, W. R., Lee, J., Glass, D. J., and Shoelson, S. E. (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285-298
12. Marinovic, A. C., Zheng, B., Mitch, W. E., and Price, S. R. (2007) Tissue-specific regulation of ubiquitin (UbC) transcription by glucocorticoids: In vivo and in vitro analyses. Am. J. Physiol. Renal Physiol. 292, F660-F666
13. Hu, Z., Wang, H., Lee, I. H., Du, J., and Mitch, W. E. (2009) Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J. Clin. Invest. 119, 3059-3069
14. Sun, X., Fischer, D. R., Pritts, T. A., Wray, C. J., and Hasselgren, P. O. (2002) Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle. Am. J. Physiol. 282, R509-R518
15. Giorgino, F., Almahfouz, A., Goodyear, L. J., and Smith, R. J. (1993) Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J. Clin. Invest. 91, 2020-2030
16. Saad, M. J. A., Folli, F., Kahn, J. A., and Kahn, C. R. (1993) Modulation of insulin receptor, insulin receptor substrate-1 and phoshatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J. Clin. Invest. 92, 2065-2072
17. Giorgino, F., Pedrini, M. T., Matera, L., and Smith, R. J. (1997) Specific increase in p85α expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J. Biol. Chem. 272, 7455-7463
18. Mitch, W. E., Bailey, J. L., Wang, X., Jurkovitz, C., Newby, D., and Price, S. R. (1999) Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. Cell Physiol. 276, C1132-C1138
19. Price, S. R., Bailey, J. L., Wang, X., Jurkovitz, C., England, B. K., Ding, X., Phillips, L. S., and Mitch, W. E. (1996) Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin proteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98, 1703-1708
20. Franch, H. A., Raissi, S., Wang, X., Zheng, B., Bailey, J. L., and Price, S. R. (2004) Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis. Am. J. Physiol. Renal Physiol. 287, F700-F706
21. Gao, Y., Ordas, R., Klein, J. D., and Price, S. R. (2008) Regulation of caspase-3 activity by insulin in skeletal muscle cells involves PI3-kinase and MEK1/2. J. Appl. Physiol. 105, 1772-1778
22. Ibrahim, N. M., Marinovic, A. C., Price, S. R., Young, L. G., and Frohlich, O. (2000) Pitfall of an internal control plasmid: response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone. BioTechniques 29, 782-784
23. Marinovic, A. C., Mitch, W. E., and Price, S. R. (2000) Tools for evaluating ubiquitin (UbC) gene expression: characterization of the rat UbC promoter and use of an unique 3′ mRNA sequence. Biochem. Biophys. Res. Commun. 274, 537-541
24. Hayashi, T., Noga, M., and Matsuda, M. (1994) Nucleotide sequence and expression of the rat polyubiquitin mRNA. Biochim. Biophys. Acta 1218, 232-234
25. Sacheck, J. M., Ohtsuka, A., McLary, S. C., and Goldberg, A. L. (2004) IGF-1 stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin-ligases, atrogin-1 and MuRF1. Am. J. Physiol. Endocrinol. Metab. 287, E591-E601
26. Bondesen, B. A., Mills, S. T., Kegley, K. M., and Pavlath, G. K. (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 287, C475-C483
27. Huang, C., Thirone, A. C., Huang, X., and Klip, A. (2005) Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in L6 myotubes. J. Biol. Chem. 280, 19426-19435
28. Folli, F., Saad, M. J. A., Backer, J. M., and Kahn, C. R. (1992) Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J. Biol. Chem. 267, 22171-22177
29. Jurkovitz, C. T., England, B. K., Ebb, R. G., and Mitch, W. E. (1992) Influence of ammonia and pH on protein and amino acid metabolism in LLC-PK1 cells. Kidney Int. 42, 595-601
30. 3H1 myocytes require an interaction between glucocorticoids and acidification. Proc. Natl. Acad. Sci. U. S. A. 97, 1967-1971
31. Gulve, E. A., and Dice, J. F. (1989) Regulation of protein synthesis and degradation in L8 myotubes: effects of serum, insulin, and insulin-like growth factors. Biochem. J. 260, 377-387
32. Du, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., and Mitch, W. E. (2004) Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J. Clin. Invest. 113, 115-123
33. Workeneh, B. T., Rondon-Berrios, H., Zhang, L., Hu, Z., Ayehu, G., Ferrando, A., Kopple, J. D., Wang, H., Storer, T., Fournier, M., Lee, S. W., Du, J., and Mitch, W. E. (2006) Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J. Am. Soc. Nephrol. 17, 3233-3239
34. Zhao, J., Brault, J. J., Schild, A., Cao, P., Sandri, M., Schiaffino, S., Lecker, S. H., and Goldberg, A. L. (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6, 472-483
35. Guo, S., Dunn, S. L., and White, M. F. (2006) The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling. Mol. Endocrinol. 20, 3389-3399
36. Ide, T., Shimano, H., Yahagi, N., Matsuzaka, T., Nakakuki, M., Yamamoto, T., Nakagawa, Y., Takahashi, A., Suzuki, H., Sone, H., Toyoshima, H., Fukamizu, A., and Yamada, N. (2004) SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6, 351-357
37. Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., and Goldberg, A. L. (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18, 39-51
38. Haas, A. L., Baboshina, O., Williams, B., and Schwartz, L. M. (1995) Coordinated induction of the ubiquitin conjugation pathway accompanies the devolopmentally programmed death of insect skeletal muscle. J. Biol. Chem. 270, 9407-9412
39. Haas, A. L., and Bright, P. M. (1987) The dynamics of ubiquitin pools within cultured human lung fibroblasts. J. Biol. Chem. 262, 345-351
40. Hanna, J., Leggett, D. S., and Finley, D. (2003) Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol. Cell. Biol. 23, 9251-9261
41. Shabek, N., Herman-Bachinsky, Y., and Ciechanover, A. (2009) Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc. Natl. Acad. Sci. U. S. A. 106, 11907-11912
42. Mitch, W. E., and Goldberg, A. L. (1996) Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335, 1897-1905
43. Waddell, D. S., Baehr, L. M., van den Brandt, J., Johnsen, S. A., Reichardt, H. M., Furlow, J. D., and Bodine, S. C. (2008) The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy associated with MuRF1 gene. Am. J. Physiol. Endocrinol. Metab. 295, E785-E797
44. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., Pan, Z. Q., Valenzuela, D. M., DeChiara, T. M., Stitt, T. N., Yancopoulos, G. D., and Glass, D. J. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708
45. Leis, H., Page, A., Ramirez, A., Bravo, A., Segrelles, C., Paramio, J., Barettino, D., Jorcano, J. L., and Perez, P. (2004) Glucocorticoid receptor counteracts tumorigenic activity of akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol. Endocrinol. 18, 303-311
46. Nakao, R., Hirasaka, K., Goto, J., Ishidoh, K., Yamada, C., Ohno, A., Okumura, Y., Nonaka, I., Yasutomo, K., Baldwin, K. M., Kominami, E., Higashibata, A., Nagano, K., Tanaka, K., Yasui, N., Mills, E. M., Takeda, S., and Nikawa, T. (2009) Ubiquitin ligase Cbl-b is a negative regulator for IGF-1 signaling during muscle atrophy caused by unloading. Mol. Cell. Biol. 29, 4798-4811
47. Thirone, A. C., Huang, C., and Klip, A. (2006) Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol. Metab. 17, 72-78
48. Plum, L., Wunderlich, F. T., Baudler, S., Krone, W., and Bruning, J. C. (2005) Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives. Physiology 20, 152-161
49. Gazdag, A. C., Dumke, C. L., Kahn, C. R., and Cartee, G. D. (1999) Calorie restriction increases insulin-stimulated glucose transport in skeletal muscle from IRS-1 knockout mice. Diabetes 48, 1930-1936
50. Shirakami, A., Toyonaga, T., Tsuruzoe, K., Shirotani, T., Matsumoto, K., Yoshizato, K., Kawashima, J., Hirashima, Y., Miyamura, N., Kahn, C. R., and Araki, E. (2002) Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J. Endocrinol. 174, 309-319
51. Bailey, J. L., Zheng, B., Hu, Z., Price, S. R., and Mitch, W. E. (2006) Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J. Am. Soc. Nephrol. 17, 1388-1394
52. Calnan, D. R., and Brunet, A. (2008) The FoxO code. Oncogene 27, 2276-2288
53. Mitchell, P. J., and Tijan, R. (1988) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245, 371-378
54. Lee, J. A., Suh, D. C., Kang, J. E., Kim, M. H., Park, H., Lee, M. N., Kim, J. M., Jeon, B. N., Roh, H. E., Yu, M. Y., Choi, K. Y., Kim, K. Y., and Hur, M. W. (2005) Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J. Biol. Chem. 280, 28061-28071
55. Alroy, I., Soussan, L., Seger, R., and Yarden, Y. (1999) Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol. Cell. Biol. 19, 1961-1972
56. Armstrong, S. A., Barry, D. A., Leggett, R. W., and Mueller, C. R. (1997) Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J. Biol. Chem. 272, 13489-13495
57. Courey, A. J., and Tjian, R. (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898
58. Fojas, d. B., Collins, N. K., Du, P., Azizkhan-Clifford, J., and Mudryj, M. (2001) Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 20, 5737-5747
59. Garcia, A., Cereghini, S., and Sontag, E. (2000) Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters. J. Biol. Chem. 275, 9385-9389